Basic Information
Elios Therapeutics, LLC is a biopharmaceutical company developing a range of innovative therapeutic cancer vaccines aimed at addressing unmet medical needs across a wide array of tumor types. Elios' lead product, TLPLDC, is a personalized therapeutic cancer vaccine designed to attack cancer cells by igniting innate and adaptive immune responses, which increase the patient’s own T-cell production to fight their specific cancer.